ADVISORS

Jane Wasman, J.D.

Board Chair of Sellas Life Sciences and Director of Rigel Pharmaceuticals.  Previously President, General Counsel of Acorda Therapeutics, Vice President, Schering-Plough.  A strategic leader with extensive U.S. and international biopharma experience including M&A, strategic development, corporate governance, international, litigation, commercial, compliance and government affairs, as well as operational implementation.
 

Jonathan Schatz, M.D.

Dr. Schatz is a physician-scientist at the University of Miami. Dr. Schatz’s work focuses on novel therapies for non-Hodgkin lymphomas. He treats patients affected by these diseases at the Sylvester Comprehensive Cancer Center (SCCC). Dr. Schatz also serves as the leader for the Development of Biologic and Molecular Therapies (DBMT) program at SCCC. Dr Schatz has expertise in murine lymphoma models, focusing on genetically accurate immunocompetent systems. He also employs genomic, biochemical, molecular biologic, and tissue culture techniques in understanding mechanisms of lymphomagenesis. 

Dr. Nassif is an artificial intelligence and machine learning scientist with background and expertise in the biomedical domain. He is an expert in computational modeling techniques, with over 15 years of algorithmic research and innovation. With a formal training and years of work and research in both the computer science and biomedical fields, Dr. Nassif has an extensive experience in inventing and applying machine learning algorithms for protein-binding modeling and breast cancer detection.

Houssam Nassif, Ph.D.

Dr. Campagna is currently the Chief Medical Officer at Intercept Pharmaceuticals. He graduated from the combined MD/PhD program at The University of Miami in 1997 with a Ph.D. in Molecular and Cellular Pharmacology, and then completed his post-doctoral fellowship, Internal Medicine internship, Anesthesia and Critical Care residency, and Cardio-Thoracic Anesthesia fellowship all at the Massachusetts General Hospital in Boston. He is a board-certified critical care anesthesiologist.

Jason Campagna, M.D./Ph.D.

Robert Rubin, J.D.

Robert is a former M&A and corporate securities lawyer.   He is a serial entrepreneur that has created, operated and sold several businesses.  He has spent the last several years as an adjunct professor in entrepreneurship and an advisor for many businesses.  His main passion is in working with teams to accelerate growth of early stage companies.   Robert has been a board member of both public and private companies.  He is currently an investment banker who raises capital for early and mid-stage companies.

 

Michael Wilson

Michael is a serial entrepreneur, engineer, and educator.  Michael founded and sold several startup companies, and consults with many Fortune 500 global brands as a catalyst for entrepreneurial ventures with idea brokering, C-level influencing, and major advisory/board expertise.  Michael is the current Faculty Director of Entrepreneurship at the Herbert Miami Business School.